GB919109913A
GB9109913D0
(en)
|
1991-05-07 |
1991-05-07 |
Medicaments
|
IL10050291A
IL100502A
(en)
|
1991-01-03 |
1991-12-25 |
Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
|
IE920004A
IE73642B1
(en)
|
1991-01-03 |
1992-01-02 |
Medicaments
|
EP92901354A
EP0565549B1
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b
|
DK92901354.8T
DK0565549T3
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolannucleoside analogues for the preparation of a preparation for the treatment of hepatitis B
|
US08/084,222
US5532246A
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
|
CA002100269A
CA2100269C
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1, 3-oxathiolane nucleoside analogues in the treatment of hepatitis b
|
TJ94000150A
TJ249B
(en)
|
1991-01-03 |
1992-01-03 |
1,3-Oxathiolane nucleoside analogues their use
|
AU11534/92A
AU660650B2
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
|
AT92901354T
ATE120644T1
(en)
|
1991-01-03 |
1992-01-03 |
USE OF 1,3-OXATHIOL ANALOGUES OF NUCLEOSIDES FOR PRODUCING A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS-B.
|
DE69201948T
DE69201948T2
(en)
|
1991-01-03 |
1992-01-03 |
USE OF 1,3-OXATHIOL ANALOGS OF NUCLEOSIDES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING HEPATITIS-B.
|
US09/585,431
USRE39155E1
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
|
PCT/CA1992/000001
WO1992011852A1
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b
|
MD95-0086A
MD1224C2
(en)
|
1991-01-03 |
1992-01-03 |
Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
|
PH43730A
PH31397A
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in thetreatment of hepatitis b.
|
GEAP19922644A
GEP19981482B
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3 - Oxatiolan Nucleozides Analoges for Treatment of Hepatitis B
|
EP92300056A
EP0494119A1
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B
|
ES92901354T
ES2070628T3
(en)
|
1991-01-03 |
1992-01-03 |
USE OF COMPOUNDS ANALOGED TO 1,3-OXATIOLANE-NUCLEOSIDES IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS B.
|
JP4501365A
JP2659863B2
(en)
|
1991-01-03 |
1992-01-03 |
Use of 1,3-oxathiolane nucleoside analogs for the treatment of hepatitis B
|
CA002254613A
CA2254613A1
(en)
|
1991-01-03 |
1992-01-03 |
1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b
|
TW081102738A
TW202385B
(en)
|
1991-01-03 |
1992-04-09 |
|
KR1019930701998A
KR0156747B1
(en)
|
1991-01-03 |
1993-07-02 |
Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
|
NO932442A
NO180407C
(en)
|
1991-01-03 |
1993-07-05 |
Use of 1,3-oxathiolannucleoside analogues in the manufacture of a medicament for the treatment of hepatitis B
|
EE9400302A
EE02995B1
(en)
|
1991-01-03 |
1994-10-20 |
Use of 1,3-oxathiolane nucleoside analogues for the preparation of hepatitis B drugs
|
GR940402226T
GR3015694T3
(en)
|
1991-01-03 |
1995-04-06 |
Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b.
|
HK159395A
HK159395A
(en)
|
1991-01-03 |
1995-10-12 |
Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis b
|
CY9802047A
CY2047B1
(en)
|
1991-01-03 |
1998-04-30 |
Use of 1,3-oxathiolane nucleoside analogues in the manufacture of a medicament for treatment of hepatitis B
|